Clin2
NCT05807256Possibly a fitRecruiting

Fertility treatments for people with immune system joint diseases

Rheumatic DiseasesFertility DisordersPregnancy, High RiskPregnancy ComplicationsImmunologic Disease

Part of Bones, joints & muscles, Immune system & allergy, Skin, Women’s health & pregnancy clinical trials.

This trial looks at fertility (“medically assisted fertilization,” such as IVF) for people with certain immune-related rheumatology conditions (like lupus, rheumatoid arthritis, or vasculitis). It may help patients and their clinicians understand which fertility approach works best and is safe for this group.

Summary written for real people, not researchers, by Clin2.

Phase
N/A
Enrollment
500 people
Ages
18 years to 50 years
Study type
Observational

Who can take part

  • You have a diagnosis of a systemic (whole-body) immune rheumatology condition such as lupus (SLE), antiphospholipid syndrome (APS), rheumatoid arthritis (RA), or similar diseases
  • You have had at least one fertility procedure called a PMA between January 2000 and April 2021
  • Your most recent follow-up visit happened by February 2022
  • Your condition is not only one-isolated organ problem (for example, only type 1 diabetes, Hashimoto’s thyroiditis, celiac, or inflammatory bowel disease without a systemic disease)
  • You do not have severe kidney failure, or serious heart/lung problems such as significant pulmonary hypertension or severe cardiomyopathy

View the official record on ClinicalTrials.gov

Quick eligibility check

Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.

Similar studies

Other trials that look related to this one.

NCT07150000Recruiting
Rheumatic disease research study for patients and healthy volunteers

This study is for people with certain rheumatic conditions (like arthritis, lupus, or vasculitis) and for healthy volunteers. It aims to learn more about these diseases and improve how they are treated.

Bonn, North Rhine-Westphalia
NCT07782450Not yet recruiting· Phase 1/Phase 2
Study of PF-08154225 for autoimmune diseases

This trial is testing an investigational medicine called PF-08154225 for people with autoimmune diseases like rheumatoid arthritis, lupus, myositis, or systemic sclerosis. It aims to see if the drug is safe and effective in reducing disease activity.

NCT05775211Recruiting
PBMC immune therapy added during fertility treatment

This trial studies whether giving your own immune cells (PBMC) to the uterus, modified with interferon (IFN‑t), can improve how endometrial (uterine lining) cells behave during infertility treatment. It may help some people with primary infertility who are undergoing assisted reproduction.

Sofia, Sofia
NCT07188285Enrolling by invitation
Immune system study for active autoimmune diseases

This study uses a blood test called mass spectrometry to look at the immune system in people with active autoimmune diseases. It aims to find patterns that could help doctors better understand and treat these conditions.

Beijing, Beijing Municipality
NCT07515638Recruiting
Immune System Study for Autoimmune Diseases

This research study collects samples and information from people with rheumatoid arthritis, lupus, or scleroderma, plus healthy volunteers, to better understand how the immune system works in these conditions. By comparing these groups, researchers hope to find new ways to treat and manage autoimmune diseases.

Montpellier
NCT06980597Recruiting· Phase 1
Testing OL-108 for active autoimmune diseases

This trial tests an investigational drug called OL-108 for people with certain autoimmune diseases (lupus, myositis, scleroderma, or vasculitis) that have come back or not responded to standard treatments. The goal is to see if it's safe and if it can help control the disease.

Beijing

Hear when a new Rheumatic Diseases trial opens

We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.